Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Biomarker Discovery Outsourcing Services Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Impact of International Trade Policies on Analytical Instruments
      2. Economic Recovery and Increased Research Spending in Healthcare
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Biomarker Type Demand Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Global Biomarker Discovery Outsourcing Services Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
   3. Global Biomarker Discovery Outsourcing Services Market Outlook: Biomarker Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Biomarker Type, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2025 - 2032
         1. Predictive Biomarkers
         2. Prognostic Biomarkers
         3. Safety Biomarkers
         4. Surrogate Biomarkers
      4. Market Attractiveness Analysis: Biomarker Type
   4. Global Biomarker Discovery Outsourcing Services Market Outlook: Therapeutic Area
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
         1. Oncology
         2. Cardiology
         3. Neurology
         4. Autoimmune Diseases
         5. Others
      4. Market Attractiveness Analysis: Therapeutic Area
   5. Global Biomarker Discovery Outsourcing Services Market Outlook: Discovery Phase
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Discovery Phase, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Discovery Phase, 2025 - 2032
         1. Biomarker Identification
         2. Biomarker Validation
         3. Biomarker Profiling
         4. Biomarker Panel Development
         5. Biomarker Selection
      4. Market Attractiveness Analysis: Discovery Phase
   6. Global Biomarker Discovery Outsourcing Services Market Outlook: End Use
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End Use, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
         1. Pharmaceutical Companies
         2. Biotechnology Companies
         3. Others
      4. Market Attractiveness Analysis: End Use
5. Global Biomarker Discovery Outsourcing Services Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Biomarker Discovery Outsourcing Services Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Therapeutic Area
      4. By Discovery Phase
      5. By End Use
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. 1. 1. Predictive Biomarkers
            2. Prognostic Biomarkers
            3. Safety Biomarkers
            4. Surrogate Biomarkers
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Autoimmune Diseases
      5. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Discovery Phase, 2025 - 2032
      1. Biomarker Identification
      2. Biomarker Validation
      3. Biomarker Profiling
      4. Biomarker Panel Development
      5. Biomarker Selection
   7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Others
   8. Market Attractiveness Analysis
7. Europe Biomarker Discovery Outsourcing Services Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Therapeutic Area
      4. By Discovery Phase
      5. By End Use
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. 1. 1. Predictive Biomarkers
            2. Prognostic Biomarkers
            3. Safety Biomarkers
            4. Surrogate Biomarkers
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Autoimmune Diseases
      5. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Discovery Phase, 2025 - 2032
      1. Biomarker Identification
      2. Biomarker Validation
      3. Biomarker Profiling
      4. Biomarker Panel Development
      5. Biomarker Selection
   7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Others
   8. Market Attractiveness Analysis
8. East Asia Biomarker Discovery Outsourcing Services Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Therapeutic Area
      4. By Discovery Phase
      5. By End Use
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. 1. 1. Predictive Biomarkers
            2. Prognostic Biomarkers
            3. Safety Biomarkers
            4. Surrogate Biomarkers
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Autoimmune Diseases
      5. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Discovery Phase, 2025 - 2032
      1. Biomarker Identification
      2. Biomarker Validation
      3. Biomarker Profiling
      4. Biomarker Panel Development
      5. Biomarker Selection
   7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Others
   8. Market Attractiveness Analysis
9. South Asia & Oceania Biomarker Discovery Outsourcing Services Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Therapeutic Area
      4. By Discovery Phase
      5. By End Use
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. 1. 1. Predictive Biomarkers
            2. Prognostic Biomarkers
            3. Safety Biomarkers
            4. Surrogate Biomarkers
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Autoimmune Diseases
      5. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Discovery Phase, 2025 - 2032
      1. Biomarker Identification
      2. Biomarker Validation
      3. Biomarker Profiling
      4. Biomarker Panel Development
      5. Biomarker Selection
   7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Others
   8. Market Attractiveness Analysis
10. Latin America Biomarker Discovery Outsourcing Services Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Biomarker Type
       3. By Therapeutic Area
       4. By Discovery Phase
       5. By End Use
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2025 - 2032
       1. 1. 1. Predictive Biomarkers
             2. Prognostic Biomarkers
             3. Safety Biomarkers
             4. Surrogate Biomarkers
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
       1. Oncology
       2. Cardiology
       3. Neurology
       4. Autoimmune Diseases
       5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Discovery Phase, 2025 - 2032
       1. Biomarker Identification
       2. Biomarker Validation
       3. Biomarker Profiling
       4. Biomarker Panel Development
       5. Biomarker Selection
    7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
       1. Pharmaceutical Companies
       2. Biotechnology Companies
       3. Others
    8. Market Attractiveness Analysis
11. Middle East & Africa Biomarker Discovery Outsourcing Services Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Biomarker Type
       3. By Therapeutic Area
       4. By Discovery Phase
       5. By End Use
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2025 - 2032
       1. 1. 1. Predictive Biomarkers
             2. Prognostic Biomarkers
             3. Safety Biomarkers
             4. Surrogate Biomarkers
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2025 - 2032
       1. Oncology
       2. Cardiology
       3. Neurology
       4. Autoimmune Diseases
       5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Discovery Phase, 2025 - 2032
       1. Biomarker Identification
       2. Biomarker Validation
       3. Biomarker Profiling
       4. Biomarker Panel Development
       5. Biomarker Selection
    7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025 - 2032
       1. Pharmaceutical Companies
       2. Biotechnology Companies
       3. Others
    8. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Laboratory Corporation of America Holdings
          1. Overview
          2. Segments and Biomarker Types
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Celerion
       3. Charles River Laboratories
       4. Eurofins Scientific
       5. GHO Capital
       6. ICON plc
       7. Evotec
       8. Parexel International (MA) Corporation
       9. Thermo Fisher Scientific Inc.
       10. Proteome Sciences
       11. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations